4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

509.09p
   
  • Change Today:
    -15.91p
  • 52 Week High: 790.00
  • 52 Week Low: 440.83
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 19
  • Market Cap: £79.11m
  • Beta: 0.00

Deal with Barclays    Trade now with Barclays Stockbrokers

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1039.6% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 48.6 n/a
Pr/Book 8.1  
Latest F'cast
Revenue 81.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

4basebio Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 0.34 (3.64) (26.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.27 (5.93) (0.42)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.51 (8.35) (0.62)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.93 (12.65) (0.94)p n/a n/a n/a n/a 0.0%
31-Dec-25 1.69 (17.60) (1.09)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4basebio Company Announcements

4basebio Plc - Result of Retail Offer 21-Oct-2026 15:00 PR Newswire
4basebio Plc - Posting of Circular and Notice of... 20-Oct-2026 07:00 PR Newswire
4basebio Plc - Proposed Retail Offer 15-Oct-2026 16:00 PR Newswire

4basebio ShareCast News

4basebio appoints Dr Jeff Coller to advisory board 15-Jun-2026 ShareCast
4basebio inks clinical supply deal 20-May-2026 ShareCast
4basebio taps Richard Bungay as new finance chief 14-May-2026 ShareCast

Latest 4basebio Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

4basebio Market Data

Currency UK Pounds
Share Price 509.09p
Change Today -15.91p
% Change -3.03 %
52 Week High 790.00
52 Week Low 440.83
Volume 19
Shares Issued 15.54m
Market Cap £79.11m
Beta 0.00

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average66.98% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Price Trend
85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average85.18% below the market average
53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average53.49% below the sector average
Income Not Available
Growth
62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average62.12% above the market average
85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average85.71% above the sector average

4basebio Dividends

No dividends found

Trades for 21-Oct-2026

Time Volume / Share Price
08:30 19 @ 526.00p

4basebio Key Personnel

CFO David John Roth
CEO Amy Walker
COO Scott Lorimer

Top of Page